Chloé Rousseau1, Marine Guichard2, Elie Saliba1,3, Baptiste Morel3,4, Geraldine Favrais5,6,7. 1. Neonatology Department, CHRU de Tours, Tours, France. 2. Pediatric Neurology Department, CHRU de Tours, Tours, France. 3. UMR 1253, iBrain, Université de Tours, INSERM, Tours, France. 4. Pediatric Radiology Department, CHRU de Tours, Tours, France. 5. Neonatology Department, CHRU de Tours, Tours, France. g.favrais@chu-tours.fr. 6. UMR 1253, iBrain, Université de Tours, INSERM, Tours, France. g.favrais@chu-tours.fr. 7. Service de Néonatologie-Hôpital Bretonneau, CHRU de Tours, 2, Boulevard Tonnellé, 37044, Tours Cedex 9, France. g.favrais@chu-tours.fr.
Abstract
Hydrocortisone is used in preterm infants. However, early disruption of growth velocities was observed in infants exposed to hydrocortisone. This retrospective study aimed to explore the postnatal brain growth of extremely preterm infants requiring hydrocortisone treatment as well as its association with perinatal factors. Extremely preterm infants exposed to hydrocortisone from 2011 to 2016 who survived up to 12 months were included. Each of them was matched with two infants not treated with hydrocortisone exhibiting similar gestational ages and nearly similar birth head circumferences. The outcome variables were brain tissue areas on MRIs performed at term-equivalent age and postnatal head circumference growth up to a corrected age of 12 months. Univariate and multiple regression analyses were performed. Infants treated with hydrocortisone (n=20) were matched with 40 infants not exposed to hydrocortisone. The infants exposed to hydrocortisone exhibited a lower birth weight (p=0.04) and a longer duration of mechanical ventilation (p<0.0001). Infants treated with hydrocortisone exhibited a smaller basal ganglia/thalamus area (p=0.04) at term-equivalent age and a smaller head circumference at a corrected age of 12 months (p=0.003). However, the basal ganglia/thalamus area and the postnatal brain growth were independently associated with the duration of mechanical ventilation and not with hydrocortisone. Interestingly, a significant interaction between hydrocortisone and sex was observed (p=0.04). Conclusion: This study supports previous data that indicated no obvious impact of hydrocortisone on brain growth and highlights the relationship between the severity of the neonatal course and postnatal brain growth in extremely preterm infants. What is Known: • Postnatal hydrocortisone disrupts transiently growth velocities including the head circumference growth. • Postnatal hydrocortisone has less impact on neurodevelopment than dexamethasone. What is New: • Hydrocortisone prescribed for infants in the most severe conditions did not show independent effect on brain growth up to the corrected age of 12 months. However, a different effect of hydrocortisone according to sex can't be excluded and needs further explorations. • Perinatal factors as birth weight and duration of mechanical ventilation were determinant for the subsequent brain growth.
Hydrocortisone is used in preterm infants. However, early disruption of growth velocities was observed in infants exposed to hydrocortisone. This retrospective study aimed to explore the postnatal brain growth of extremely preterm infants requiring hydrocortisone treatment as well as its association with perinatal factors. Extremely preterm infants exposed to hydrocortisone from 2011 to 2016 who survived up to 12 months were included. Each of them was matched with two infants not treated with hydrocortisone exhibiting similar gestational ages and nearly similar birth head circumferences. The outcome variables were brain tissue areas on MRIs performed at term-equivalent age and postnatal head circumference growth up to a corrected age of 12 months. Univariate and multiple regression analyses were performed. Infants treated with hydrocortisone (n=20) were matched with 40 infants not exposed to hydrocortisone. The infants exposed to hydrocortisone exhibited a lower birth weight (p=0.04) and a longer duration of mechanical ventilation (p<0.0001). Infants treated with hydrocortisone exhibited a smaller basal ganglia/thalamus area (p=0.04) at term-equivalent age and a smaller head circumference at a corrected age of 12 months (p=0.003). However, the basal ganglia/thalamus area and the postnatal brain growth were independently associated with the duration of mechanical ventilation and not with hydrocortisone. Interestingly, a significant interaction between hydrocortisone and sex was observed (p=0.04). Conclusion: This study supports previous data that indicated no obvious impact of hydrocortisone on brain growth and highlights the relationship between the severity of the neonatal course and postnatal brain growth in extremely preterm infants. What is Known: • Postnatal hydrocortisone disrupts transiently growth velocities including the head circumference growth. • Postnatal hydrocortisone has less impact on neurodevelopment than dexamethasone. What is New: • Hydrocortisone prescribed for infants in the most severe conditions did not show independent effect on brain growth up to the corrected age of 12 months. However, a different effect of hydrocortisone according to sex can't be excluded and needs further explorations. • Perinatal factors as birth weight and duration of mechanical ventilation were determinant for the subsequent brain growth.
Authors: Rebecca J Scharf; Annemarie Stroustrup; Mark R Conaway; Mark D DeBoer Journal: Arch Dis Child Fetal Neonatal Ed Date: 2015-12-01 Impact factor: 5.747
Authors: Wes Onland; Filip Cools; Andre Kroon; Karin Rademaker; Maruschka P Merkus; Peter H Dijk; Henrica L van Straaten; Arjan B Te Pas; Thilo Mohns; Els Bruneel; Arno F van Heijst; Boris W Kramer; Anne Debeer; Inge Zonnenberg; Yoann Marechal; Henry Blom; Katleen Plaskie; Martin Offringa; Anton H van Kaam Journal: JAMA Date: 2019-01-29 Impact factor: 56.272
Authors: Kristin Keunen; Ivana Išgum; Britt J M van Kooij; Petronella Anbeek; Ingrid C van Haastert; Corine Koopman-Esseboom; Petronella C Fieret-van Stam; Rutger A J Nievelstein; Max A Viergever; Linda S de Vries; Floris Groenendaal; Manon J N L Benders Journal: J Pediatr Date: 2016-01-07 Impact factor: 4.406
Authors: Manon J N L Benders; Floris Groenendaal; Frank van Bel; Russia Ha Vinh; Jessica Dubois; François Lazeyras; Simon K Warfield; Petra S Hüppi; Linda S de Vries Journal: Pediatr Res Date: 2009-11 Impact factor: 3.756
Authors: Axel R Franz; Frank Pohlandt; Harald Bode; Walter A Mihatsch; Silvia Sander; Martina Kron; Jochen Steinmacher Journal: Pediatrics Date: 2009-01 Impact factor: 7.124